India's Pharmaceutical Exports just crossed $30 Billion.💊🚀

India's pharmaceutical industry has evolved into a global healthcare powerhouse, with exports soaring from $1.5 billion in FY2001 to $30.5 billion in FY2025. Today, India is the 3rd largest pharmaceutical producer by volume and supplies 20% of the world's generic medicines, 40% of generics consumed in the United States, 50% of Africa's generic medicine demand, 25% of medicines used in the United Kingdom, and over 70% of global antiretroviral drugs. The country also has the highest number of USFDA-approved manufacturing plants outside the United States, reinforcing its position as a trusted global supplier. Looking ahead, India's pharmaceutical market is projected to expand from $58 billion today to $130 billion by 2030, supported by rising healthcare spending, increasing chronic disease prevalence, stronger domestic demand, and rapid growth in API manufacturing, biosimilars, and CDMO/CRDMO services. With a robust manufacturing ecosystem, policy support, and growing global outsourcing by innovator companies, India's pharma sector is entering a multi-year growth cycle that could benefit leading listed players across formulations, APIs, and specialty manufacturing. 📈💊